Medicines Australia commends Pfizer boss on her international role

Medicines Australia congratulates Melissa McGregor on her appointment to a new senior position for Pfizer in Europe and thank her for her contribution and commitment to the industry through her role as Deputy Chair of the Board, member of the Nominations Committee and her leadership of the review of the Medicines Australia Constitution.

Dr Anna Lavelle, Chair of Medicines Australia congratulated Ms McGregor on her promotion.

“Melissa has always shown passion for the industry and for achieving optimal patient outcomes. As Chair I will miss her high level of engagement and commitment to Medicines Australia. It is no surprise to me that her talent and energy has been recognised and I wish her every success in her new role,” said Dr Lavelle.

Medicines Australia CEO Elizabeth de Somer also paid tribute to Ms McGregor’s contribution to the Australian innovative medicines industry.

“Melissa has been a tremendous advocate for the industry in Australia and provided great personal support and advice to me as I took on the role of CEO.

Enhance employer branding and boost thought leadership in the industry to attract and retain quality employees. Health Industry Hub is the only one-stop-hub connecting your organisation to Australia’s Pharma, MedTech, and Biotech industry professionals. Get started with our unique media solutions.

“We will miss her dedication and drive on a range of issues important to us all, including her founding role in the creation of PAIG, Pharma Australia Inclusion Group (formerly Pharma Australia Gender Equality) and most recently, as a staunch advocate for a review of the National Medicines Policy and our pre-budget advocacy,” said Ms de Somer.

Melissa will remain on the Board until February 2020, when she departs for her position overseas. An announcement on the composition of the Board and Deputy Chair position will be made after the next meeting in February.

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.